FDA cleared the OsteoSight Spine (v1) from Naitive Technologies, Ltd. on Oct 27, 2026 under K261512, a traditional 510(k). The device falls under product code SAO, Radiology Software For Opportunistic Evaluation Of Low Bone Mineral Density, regulated at 21 CFR 892.1171 as a Class 2 device. The review panel was Radiology.

FDA logged the submission as received on May 7, 2026. The decision came 173 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for Naitive Technologies, Ltd. in the last 12 months of the tracker.